Ryosuke Okamura
0000-0001-7352-8621
Publication & Citation Trends
Publications
188 total
Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy PDF
Cited by 294
OpenAlex
<i>ARID1A</i> alterations function as a biomarker for longer progression-free survival after anti-PD-1/PD-L1 immunotherapy PDF
Cited by 186
OpenAlex
MHC-I genotype and tumor mutational burden predict response to immunotherapy PDF
Cited by 114
OpenAlex
High Tumor Mutational Burden Correlates with Longer Survival in Immunotherapy-Naïve Patients with Diverse Cancers PDF
Cited by 100
OpenAlex
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study PDF
Cited by 706
OpenAlex
Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer PDF
Cited by 95
OpenAlex
Analysis of <i>NTRK</i> Alterations in Pan-Cancer Adult and Pediatric Malignancies: Implications for NTRK-Targeted Therapeutics PDF
Cited by 317
OpenAlex
Research Topics
Cancer Genomics and Diagnostics
(75)
Colorectal Cancer Surgical Treatments
(35)
Gastric Cancer Management and Outcomes
(27)
Cancer Immunotherapy and Biomarkers
(26)
Genetic factors in colorectal cancer
(23)
Affiliations
Kansai Medical University
ROHM
Kyoto University
UC San Diego Health System
University of California San Diego